A NEW TECHNIQUE FOR SWEAT CHLORIDE DETERMINATION USING MOHR’S SILVER METHOD: DEVELOPEMENT AND ANALYTICAL VALIDATION
DOI:
https://doi.org/10.4314/jfas.1316Keywords:
cystic fibrosis, sweat test, Mohr’s method, analytical validation, sweat chloridesAbstract
This study presents a new technique for determining chloride ions in the sweat test for the diagnosis of cystic fibrosis. The technique developed is based on Mohr’s silver titrimetric method. The analytical development was performed on three quality control levels (C1, C2 and C3 at 25, 45 and 65 mmol/L respectively) and validated according to the requirements of ISO15189. Repeatability was estimated by the coefficient of variation (CV) at 2.45%, 3.12% and 2.21% for C1, C2 and C3. The CV estimated the intermediate precision at 4.12%, 4.51% and 2.63% for C1, C2, C3. The bias estimated the accuracy at 0.99% for C1, 2.76% for C2 and 2.55% for C3. The assays were performed following a linear calibration curve (equation: Y=0.0001 X + (3 x 10-5) with R2 =0.9995) between 0 and 150 mmol/L. This new technique is a simple and fast alternative using stable and less toxic reagents than the mercurimetric technique.
Downloads
References
Lebecque P, Proesmans O, Leal M, Teresinha J., Mucoviscidose-2019: mise en place du
dépistage néonatal en Belgique. Louvain médical, 2019. 138(09): p. 509.
Boukari R, Smati L, Benhalla K-N , Radoui K, Kaddache C, Touri S, Bioud B et al., Cystic
fibrosis: course of management in Algeria. Archives de pediatrie: organe officiel de la Societe
francaise de pediatrie, 2015. 22(5 Suppl 1): p. 5-6.
Giannantonio M, Transfert de la pédiatrie a l’adulte de patients atteints de mucoviscidose: le vécu des partients et des équipes de CHU de Nice. Médecine humaine et pathologie., 2013
Farrell P, White T, Ren C, Hempstead S, Accurso F, Derichs N et al., Diagnosis of cystic
fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. The Journal of pediatrics,
181: p. S4-S15. e1.
Charles E, Muhlebach M, Ehre C, Hill D, Wolfgang M, Kesimer M et al., Mucus
accumulation in the lungs precedes structural changes and infection in children with cystic
fibrosis. Science translational medicine, 2019. 11(486).
Radoui A, La mucoviscidose de l’enfant, in Faculté de médecine ;Oran. 2012.
Dehillotte C, Lemmonier L, Vaincre la mucoviscidose: Bilan des données 2019.
Registre français de la mucoviscidose, 2019. 52
Mucoviscidose des pistes thérapeutiques encourageantes. 2017; Available from:
www.inserm.fr/dossier/mucoviscidose/.
Welsh M, Smith A., Molecular mechanisms of CFTR chloride channel dysfunction in cystic
fibrosis. Cell, 1993. 73(7): p. 1251-1254.
Durupt S , M.S., Reix P . , La mucoviscidose en 2014: actualités thérapeutiques. Revue de
Pneumologie Clinique, 2016. 72(1): p. 77-86.
Centre de Référence Mucoviscidose de Lyon. Protocole National de Diagnostic et de Soins
(PNDS) Mucoviscidose 2017.
C., F. La mucoviscidose: du gène CFTR au conseil génétique. 2010-2011. 18.
LeGrys V, Sweat testing for the diagnosis of cystic fibrosis: practical considerations. The
Journal of pediatrics, 1996. 129(6): p. 892-897.
LeGrys V, Yankaskas J, Quittell L, Marshall B, Mogayzel P, Diagnostic sweat testing: the
Cystic Fibrosis Foundation guidelines. The Journal of pediatrics, 2007. 151(1): p. 85-89.
Mishra A, Greaves R, Massie J, The relevance of sweat testing for the diagnosis of cystic
fibrosis in the genomic era. The Clinical biochemist. Reviews/Australian Association of
Clinical Biochemists., 2005. 26(4): p. 135.
Heeley M, Woolf D, Heeley A Indirect measurements of sweat electrolyte concentration in
the laboratory diagnosis of cystic fibrosis. Archives of disease in childhood, 2000. 82(5): p.
-424.
Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D Recommandations françaises
pour la réalisation et l’interprétation du test de la sueur dans le cadre du dépistage néonatal
de la mucoviscidose. Archives de pédiatrie, 2010. 17(9): p. 1349-1358.
ISO15189: Laboratoires de biologie médicale–Exigences concernant la qualité et
la compétence. 2012; Available from: www.iso.org.
Vassault A, Hulin A, Chapuzet E, Arnaud J, Giroud C, Vérification/validation des
performances d’une méthode d’analyse. Annales de Biologie Clinique, 2010. 68(1): p. 247-
ICH Guideline M10 on Bioanalytical Method Validation. 2019; Available from:
www.ema.europa.eu/en/ich-m10-bioanalytical-method-validation.
LeGrys V, Applequist R, Briscoe D, Farrell P, Hickstein R, Lo S, et al., Sweat testing: sample
collection, quantitative chloride analysis; approved guideline- Third edition. Clin Lab Stand
Ins, 2009. 29 - number 27.
Mayell S, Munck A, Craig J, Sermet I, Brownlee K, Schwarz M et al., A European consensus
for the evaluation and management of infants with an equivocal diagnosis following newborn
screening for cystic fibrosis. Journal of Cystic Fibrosis, 2009. 8(1): p. 71-78.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Fundamental and Applied Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Submissions
